ALS

Biogen walks away from Ionis-partnered ALS, Angelman prospects after peek at clinical data
Fierce Biotech
Thu, 05/16/24 - 11:38 am
Biogen
Ionis Pharmaceuticals
ALS
Angelman Syndrome
Lots of drug companies talk about putting patients first — but this one actually did
NPR
Wed, 05/15/24 - 11:20 am
Amylyx Pharmaceuticals
ALS
patients
Trials to watch: Four ALS drugs to keep an eye on
Clinical Trials Arena
Tue, 04/30/24 - 06:34 pm
ALS
clinical trials
Calico Life Sciences
AbbVie
ABBV-CLS-7262
AL-S Pharma
AP-101
Rapa Therapeutics
RAPA-501
Clene
CNMAu-8
Amylyx at a Crossroads: Can the Company Overcome the Loss of Relyvrio?
BioSpace
Wed, 04/17/24 - 11:22 am
Amylyx
Relyvrio
ALS
FDA gives nod to BrainStorm for ALS trial after Phase III flop
Clinical Trials Arena
Tue, 04/9/24 - 11:39 am
BrainStorm Cell Therapeutics
clinical trials
NurOwn
FDA
ALS
Amylyx to pull ALS drug Relyvrio From US, Canada markets after phase III fail
BioSpace
Thu, 04/4/24 - 11:25 am
Amylyx Pharmaceuticals
ALS
Relyvrio
European study finds popular ALS drug ineffective
BioPharma Dive
Wed, 03/27/24 - 10:31 pm
Amylyx
TUDCA
ALS
clinical trials
Europe
Seelos’ IV-administered sugar therapy fails to improve ALS severity in midstage trial
Fierce Biotech
Tue, 03/19/24 - 11:19 am
Seelos Therapeutics
ALS
SLS-005
clinical trials
Setbacks reset views on highly touted Alzheimer's and ALS drugs
Axios
Mon, 03/11/24 - 05:06 pm
Alzheimer's disease
ALS
Amylyx
Relyvrio
Eli Lilly
donanemab
After trial failure, will Amylyx pull ALS drug Relyvrio off the market?
Fierce Pharma
Fri, 03/8/24 - 11:33 am
Amylyx
ALS
Relyvrio
ALS Treatment Landscape ‘Primed’ with Over 100 Candidates: GlobalData
BioSpace
Mon, 03/4/24 - 11:44 am
ALS
drug development
Biogen partner NeuroSense seeks a role in the ALS revolution
Pharma Voice
Fri, 03/1/24 - 11:24 am
NeuroSense Therapeutics
Biogen
ALS
EU medicines regulator backs Biogen's ALS drug
Reuters
Fri, 02/23/24 - 10:28 am
Biogen
Europe
ALS
Qalsody
Denali-Sanofi's ALS drug fails to meet mid-stage trial goal
Reuters
Fri, 02/16/24 - 11:36 am
Denali Therapeutics
Sanofi
ALS
clinical trials
6 Neuro Data Readouts to Watch in the First Half of 2024
BioSpace
Mon, 01/22/24 - 11:53 am
neurodegenerative disease
clinical trials
ALS
major depressive disorder
Huntington's disease
Sanofi
Denali Therapeutics
Intra-Cellular Therapies
lumateperone
Annexon Biosciences
Guillain-Barré Syndrome
ANX005
Wave Life Sciences
Praxis Precision Medicines
FDA Denies Accelerated Approval for Clene’s ALS Candidate
BioSpace
Thu, 12/21/23 - 11:31 am
Clene
ALS
FDA
CNM-Au8
Coya taps familiar friend Dr. Reddy’s to commercialize ALS med
Fierce Biotech
Wed, 12/6/23 - 08:58 pm
Coya Therapeutics
ALS
Dr Reddy's
COYA 302
NeuroSense’s trial of ALS drug meets primary and secondary endpoints
Clinical Trials Arena
Wed, 12/6/23 - 10:22 am
NeuroSense Therapeutics
clinical trials
PrimeC
ALS
Merck-backed VectorY Therapeutics raises $138M series A to push forward ALS program
Fierce Biotech
Tue, 11/14/23 - 09:28 am
VectorY Therapeutics
funding
ALS
Merck
BrainStorm lays off 30% of staff, slimming down for yet another bid to get ALS cell therapy to market
Fierce Biotech
Tue, 10/24/23 - 09:53 am
BrainStorm Cell Therapeutics
layoffs
FDA
ALS
NurOwn

Pages